D-0528-2023 Class III Terminated

Recalled by Accord Healthcare, Inc. — Durham, NC

FDA drug recall D-0528-2023 was initiated by Accord Healthcare, Inc. on Mar 29, 2023 and is designated Class III. Reason for recall: Sub-potent drug: assay test result below specifications at 9-month timepoint. The recall status is terminated (terminated Mar 19, 2025). Affected quantity: 4574 cartons.

Recall details

Product Type
Drugs
Report Date
Apr 12, 2023
Initiation Date
Mar 29, 2023
Termination Date
Mar 19, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4574 cartons

Product description

Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or Subcutaneous Use Only, Rx Only, Sterile, Manufactured by: Intas Pharmaceuticals Limited Pharmaz Ahnedabad 382 213, INDIA, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-533-08.

Reason for recall

Sub-potent drug: assay test result below specifications at 9-month timepoint.

Distribution pattern

Nationwide in the USA.

Code information

Lot #: R2200394 Exp. 03/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0528-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0528-2023. Report a data issue: hello@regdatalab.com.